Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Head & Neck 6Genitourinary 4Gynecologic 3Breast 3Other hematologic neoplasm 2Gastrointestinal 2CNS 2Tumor-Agnostic 1Thoracic 1Lymphoid 1Endocrine 1Classical hematology 1

Conditions

Brain Neoplasms 2Meningioma 1

Interventions

Temozolomide 31Magnetic Resonance Spectroscopy 31Specimen Handling 18Radiation 13Radiotherapy 12Biopsy 11Bevacizumab 11Nivolumab 9X-Rays 7Radiosurgery 7Nuclear Medicine Department, Hospital 7Carboplatin 7Lomustine 6Cyclophosphamide 6Vincristine 5Phantoms, Imaging 5Cisplatin 5ulixertinib 4trametinib 4pembrolizumab 4erdafitinib 4binimetinib 4abemaciclib 4Irinotecan 4Ipilimumab 4Immunoglobulin G 4Etoposide 4Disulfides 4Aminolevulinic Acid 4AZD 6244 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Surveys and Questionnaires × CNS × 30 days × Clear all
NCT07226466 2026-05-22

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

University of California, San Francisco

Not yet recruiting
40 enrolled
CNS

Brain Neoplasms

NCT07418775 2026-05-19

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

University of California, San Francisco

Recruiting
3,000 enrolled
CNS

Brain Neoplasms, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡